12.78  0.033 (0.26%)		05-23 15:26
Open: 12.51 High: 12.78 Volume: 4,935		Pre. Close: 12.7469 Low: 12.5 Market Cap: 9(M)

Short term
Mid term
Targets	6-month :	15.72	1-year :	18.36
Resists	First :	13.46	Second :	15.72
Pivot price	12.05
Supports	First :	12	Second :	11.1
MAs	MA(5) :	12.82	MA(20) :	11.93
	MA(100) :	12.4	MA(250) :	11.14
MACD	MACD :	0.3	Signal :	0.2
%K %D	K(14,3) :	66.7	D(3) :	73.9
RSI	RSI(14): 62.1
52-week	High :	15.93	Low :	7.13

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ PSIL ] has closed below upper band by 20.8%. Bollinger Bands are 1.9% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	12.8 - 12.84	12.84 - 12.88
Low:	12.37 - 12.43	12.43 - 12.48
Close:	12.69 - 12.78	12.78 - 12.86

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from or devote 50% of their assets to psychedelic drugs and derivatives that have economic characteristics similar to such securities. The fund primarily invests in publicly listed life sciences companies focused on psychedelic medicines as well as other companies with activities in the psychedelics business. The fund is non-diversified.

Thu, 27 Mar 2025
5 Sector ETFs That Have Outperformed the S&P 500 in Q1 - TradingView

Mon, 10 Feb 2025
Psychedelic ETF PSIL Is 2025's Best-Performing ETF - ETF.com

Thu, 30 Jan 2025
Under-the-Radar Opportunities in ETFs - ETF Trends

Thu, 17 Oct 2024
DRUG Enhances Buzz for Psilocybin, Psychedelic ETFs - ETF.com

Thu, 25 Jul 2024
Best Psychedelic ETFs - Benzinga

Mon, 17 Jun 2024
5 Psychedelic (aka magic mushroom) stocks to watch - Dr Wealth

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.